Cuidados

Oncology News

Prostate cancer patients with pretreatment obstructive urinary symptoms can experience improvement in their urinary function after external beam radiotherapy, without increasing their risk for severe genitourinary toxicity, report US researchers.

The antiapoptotic protein B-cell lymphoma 2 is a favorable prognostic marker for all types of early-stage breast cancer, independent of tumor size, grade, and stage, study findings indicate.

Epirubicin plus cyclophosphamide and epirubicin plus docetaxel are highly effective combinations for first-line chemotherapy of metastatic breast cancer, research shows.

The risk for possible disease recurrence indicated by biochemical failure after surgery for prostate cancer decreases the longer it takes to detect a patient?s prostate-specific antigen level, study findings show.

Real-time elastography-targeted prostate biopsy can detect the presence of prostate cancer using fewer cores than are needed with systematic biopsy in men with a prostate-specific antigen level between 1.25 and 4.00 ng/ml, say researchers.

A study of common genetic variants for breast cancer has revealed that a polygenic risk score is substantially more predictive of estrogen receptor-positive than of ER-negative breast cancer.

Men with prostate cancer who are aged 60 years or younger can achieve excellent 5- and 8-year biochemical control rates after treatment with brachytherapy, report US researchers.

The majority of men with low-risk prostate cancer are nonetheless treated aggressively, say US researchers who analyzed risk profiles and factors associated with treatment using the Surveillance, Epidemiology, and End Results database.

Poor body image in long-term breast cancer survivors is associated with the type of surgery received and local body changes after treatment, as well as mental distress, reduced health, and impaired quality of life, researchers report.

Prostate cancer patients treated with androgen deprivation therapy do not experience a worsening of cognition after treatment, show the results of a US study.